drugset / Trial / NCT00880685

Memantine in the Treatment of Kleptomania

NCT00880685

Phase 2 Completed 12 enrolled University of Chicago
NaSingle-groupOpen-labelTreatment

Summary

The goal of the proposed study is to evaluate the efficacy and safety of memantine in kleptomania.

Timeline

Start
2009-03
Primary completion
2012-05
Completion
2012-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Memantine Unknown 30 mg

Indications